Akèy › Leksemi mieloïd egi › New Jersey › Edison

Etid klinik pou Leksemi mieloïd egi nan Edison, NJ

20 etid pou Leksemi mieloïd egi ap chèche patisipan nan sit nan ak bò kote Edison (nan yon distans apeprè 30 mil). Louvri yon etid pou wè ki moun ki ka patisipe ak kijan pou kontakte ekip etid la.

Tèks ofisyèl etid la (Anglè)

Ap chèche patisipan pou yon etid? Mete l anwo paj sa a — $99 pou 30 jou →

Testing the Anti-cancer Drug, Cirtuvivint, and Its Combination With ASTX727 to Improve Outcomes in Patients With Acute Myeloid Leukemia and Myelodysplastic Syndromes

Ap rekriteFaz 1

Rutgers Cancer Institute of New Jersey, New Brunswick · 3 mi lwen
Memorial Sloan Kettering Basking Ridge, Basking Ridge · 15 mi lwen

Laj 18 ak plis · Tout sèks · Mizajou Oct 1, 2026 · NCT06484062

Comparing Cytarabine + Daunorubicin Therapy Versus Cytarabine + Daunorubicin + Venetoclax Versus Venetoclax + Azacitidine in Younger Patients With Intermediate Risk AML (A MyeloMATCH Treatment Trial)

Ap rekriteFaz 2

Rutgers Cancer Institute of New Jersey, New Brunswick · 3 mi lwen
Memorial Sloan Kettering Basking Ridge, Basking Ridge · 15 mi lwen

Laj 18 a 59 · Tout sèks · Mizajou Sep 28, 2026 · NCT05554393

MYELOMATCH: A Screening Study to Assign People With Myeloid Cancer to a Treatment Study or Standard of Care Treatment Within myeloMATCH (MyeloMATCH Screening Trial)

Ap rekriteFaz 2

Rutgers Cancer Institute of New Jersey, New Brunswick · 3 mi lwen
Memorial Sloan Kettering Basking Ridge, Basking Ridge · 15 mi lwen

Laj 18 ak plis · Tout sèks · Mizajou Sep 25, 2026 · NCT05564390

Venetoclax and HMA Treatment of Older and Unfit Adults With FLT3 Mutated Acute Myeloid Leukemia (AML) (A MyeloMATCH Treatment Trial)

Ap rekriteFaz 2

Rutgers Cancer Institute of New Jersey, New Brunswick · 3 mi lwen
Memorial Sloan Kettering Basking Ridge, Basking Ridge · 15 mi lwen

Laj 18 ak plis · Tout sèks · Mizajou Sep 22, 2026 · NCT06317649

A Study of CRD3874-SI in People With Leukemia

Ap rekriteFaz 1

Memorial Sloan Kettering at Basking Ridge (All Protocol Activities), Basking Ridge · 15 mi lwen

Laj 18 ak plis · Tout sèks · Mizajou Sep 22, 2026 · NCT07661095

Comparing New Treatments for People With Newly Diagnosed Acute Myeloid Leukemia That Has an IDH2 Gene Change (A MyeloMATCH Treatment Trial)

Ap rekriteFaz 2

Rutgers Cancer Institute of New Jersey, New Brunswick · 3 mi lwen
Memorial Sloan Kettering Basking Ridge, Basking Ridge · 15 mi lwen

Laj 18 ak plis · Tout sèks · Mizajou Sep 22, 2026 · NCT06672146

Testing New Therapies for Patients With Acute Myeloid Leukemia Who Are Newly Diagnosed and Have Not Yet Started Treatment (A MyeloMATCH Treatment Trial)

Ap rekriteFaz 2

Rutgers Cancer Institute of New Jersey, New Brunswick · 3 mi lwen
Memorial Sloan Kettering Basking Ridge, Basking Ridge · 15 mi lwen

Laj 18 a 59 · Tout sèks · Mizajou Sep 22, 2026 · NCT05554406

A Study to Compare Standard Chemotherapy to Therapy With CPX-351 and/or Gilteritinib for Patients With Newly Diagnosed AML With or Without FLT3 Mutations

Ap rekriteFaz 3

Saint Peter's University Hospital, New Brunswick · 3 mi lwen
Rutgers Cancer Institute of New Jersey-Robert Wood Johnson University Hospital, New Brunswick · 3 mi lwen

6 Months – 21 Years · Tout sèks · Mizajou Sep 17, 2026 · NCT04293562

The Pediatric Acute Leukemia (PedAL) Screening Trial - A Study to Test Bone Marrow and Blood in Children With Leukemia That Has Come Back After Treatment or Is Difficult to Treat - A Leukemia & Lymphoma Society and Children's Oncology Group Study

Ap rekriteFaz 1/2

Saint Peter's University Hospital, New Brunswick · 3 mi lwen
Rutgers Cancer Institute of New Jersey-Robert Wood Johnson University Hospital, New Brunswick · 3 mi lwen

Jiska laj 22 · Tout sèks · Mizajou Aug 25, 2026 · NCT04726241